Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.6.2 extracted from

  • Jonus, H.C.; Hanberry, B.S.; Khatu, S.; Kim, J.; Luesch, H.; Dang, L.H.; Bartlett, M.G.; Zastre, J.A.
    The adaptive regulation of thiamine pyrophosphokinase-1 facilitates malignant growth during supplemental thiamine conditions (2018), Oncotarget, 9, 35422-35438 .
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine TPK1 is post-transcriptionally upregulated in cancer cells following hypoxic exposure. TPK1 expression is also adaptively upregulated following alterations of redox status by chemotherapeutic and antioxidant treatments. Despite upregulation by hypoxia, intracellular TPP levels are reduced. This loss was reversed by treatment with cell-permeable antioxidants and corresponds with reduced ROS production and enhanced cellular proliferation during supplemental thiamine conditions. siRNA-mediated knockdown of TPK1 directly enhances basal ROS levels and reduces tumor cell proliferation Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens Q9H3S4
-
-

Source Tissue

Source Tissue Comment Organism Textmining
Caco-2 cell
-
Homo sapiens
-
HCT-116 cell
-
Homo sapiens
-
HuTu-80 cell
-
Homo sapiens
-
LN-18 cell
-
Homo sapiens
-
MCF-7 cell
-
Homo sapiens
-
MDA-MB-231 cell
-
Homo sapiens
-
U-87MG cell
-
Homo sapiens
-

Synonyms

Synonyms Comment Organism
Tpk1
-
Homo sapiens

General Information

General Information Comment Organism
physiological function TPK1 is post-transcriptionally upregulated in cancer cells following hypoxic exposure. TPK1 expression is also adaptively upregulated following alterations of redox status by chemotherapeutic and antioxidant treatments. Despite upregulation by hypoxia, intracellular TPP levels are reduced. This loss was reversed by treatment with cell-permeable antioxidants and corresponds with reduced ROS production and enhanced cellular proliferation during supplemental thiamine conditions. siRNA-mediated knockdown of TPK1 directly enhances basal ROS levels and reduces tumor cell proliferation Homo sapiens